These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38549551)

  • 1. Navigating through the challenges of bullous pemphigoid and breast cancer in the elderly.
    Yoo LJH; Grechin C; Kearney N; Orr E; Ryan SL; O'Kane M
    Clin Exp Dermatol; 2024 Mar; ():. PubMed ID: 38549551
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose methotrexate treatment in elderly patients with bullous pemphigoid.
    Paul MA; Jorizzo JL; Fleischer AB; White WL
    J Am Acad Dermatol; 1994 Oct; 31(4):620-5. PubMed ID: 8089289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyshidrosiform Bullous Pemphigoid.
    Cohen PR
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33924249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous pemphigoid in elderly woman affected by non-small cell lung cancer treated with pembrolizumab: A case report and review of literature.
    Cosimati A; Rossi L; Didona D; Forcella C; Didona B
    J Oncol Pharm Pract; 2021 Apr; 27(3):727-733. PubMed ID: 32772795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Management of a Case of Severe Psoriasis Coexistent with Bullous Pemphigoid in the Elderly.
    Di Lernia V; Peccerillo F; Ficarelli E
    Psoriasis (Auckl); 2023; 13():27-31. PubMed ID: 37635856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyshidrosiform Bullous Pemphigoid: Case Reports and Review.
    Cohen PR
    Cureus; 2020 Jan; 12(1):e6630. PubMed ID: 32064205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bullous pemphigoid, a dermatosis of the elderly].
    Hébert V; Joly P
    Rev Prat; 2017 Dec; 67(10):1080-1083. PubMed ID: 30512605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous Pemphigoid Masquerading as Erythrodermic Psoriasis.
    De-Kaa NLP; Adefemi SA; Akuhwa RT; Fikin A; Atabo A
    West Afr J Med; 2022 Dec; 39(12):1319-1323. PubMed ID: 36583972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic eczematous dermatitis in patients with neurodegenerative diseases may be an early marker of bullous pemphigoid.
    Chou PS; Chou TC; Chang CH; Yu S; Lee CH
    Med Hypotheses; 2017 Jun; 103():86-89. PubMed ID: 28571819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral localized bullous pemphigoid in a young adult patient: A case report.
    Nourmohammadpour P; Akhdar M; Ghanadan A; Peymanfar AA; Saberi F; Keshavarz-Fathi M
    SAGE Open Med Case Rep; 2023; 11():2050313X231190730. PubMed ID: 37533489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk heterogeneity of bullous pemphigoid among dipeptidyl peptidase-4 inhibitors: A population-based cohort study using Japanese Latter-Stage Elderly Healthcare Database.
    Harano Y; Mitamura Y; Jiang P; Fujita T; Babazono A
    J Diabetes Investig; 2023 Jun; 14(6):756-766. PubMed ID: 36897510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous pemphigoid presenting as generalized pruritus: observations in six patients.
    Alonso-Llamazares J; Rogers RS; Oursler JR; Calobrisi SD
    Int J Dermatol; 1998 Jul; 37(7):508-14. PubMed ID: 9679691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity in bullous pemphigoid: up-date and clinical implications.
    Huttelmaier J; Benoit S; Goebeler M
    Front Immunol; 2023; 14():1196999. PubMed ID: 37457698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid.
    Qiao P; Dang EL; Fang H; Zhang JY; Li B; Shen SX; Luo YX; Lei J; Shao S; Qiao HJ; Wang G
    Oncotarget; 2018 Oct; 9(85):35517-35527. PubMed ID: 30473747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous Pemphigoid Complicated by Sepsis.
    Shah D; Shah A; Nguyen VS; Falgiani M; Ganti L
    Cureus; 2022 Sep; 14(9):e28765. PubMed ID: 36211099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous pemphigoid following therapy with an oral beta-blocker.
    Perry A; Sparling JD; Pennington M
    J Drugs Dermatol; 2005; 4(6):746-8. PubMed ID: 16302561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of paraneoplastic bullous pemphigoid in association with squamous cell carcinoma of lung.
    Das A; Das S; Das SK; Basuthakur S
    J Postgrad Med; 2015; 61(3):197-9. PubMed ID: 26119440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches.
    Chen HC; Wang CW; Toh WH; Lee HE; Chung WH; Chen CB
    Clin Rev Allergy Immunol; 2023 Dec; 65(3):331-353. PubMed ID: 37897588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of bullous pemphigoid in Sweden 2005-2012: a nationwide population-based cohort study of 3761 patients.
    Thorslund K; Seifert O; Nilzén K; Grönhagen C
    Arch Dermatol Res; 2017 Nov; 309(9):721-727. PubMed ID: 28875235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous pemphigoid associated with squamous cell lung carcinoma showing remarkable response to carboplatin-based chemotherapy:  a case report.
    Shrestha P; George MK; Baidya S; Rai SK
    J Med Case Rep; 2022 May; 16(1):184. PubMed ID: 35513831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.